Detalhe da pesquisa
1.
Genomics to select treatment for patients with metastatic breast cancer.
Nature
; 610(7931): 343-348, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071165
2.
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Breast Cancer Res Treat
; 204(2): 237-248, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112922
3.
Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
Am J Obstet Gynecol
; 230(3): 362.e1-362.e8, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37722570
4.
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patients.
Int J Gynecol Cancer
; 34(4): 574-580, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242546
5.
Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic Tumors.
Mod Pathol
; 36(1): 100046, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788063
6.
Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective Study.
Ann Surg Oncol
; 30(6): 3304-3315, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729351
7.
Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trial.
Gynecol Oncol
; 168: 62-67, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401942
8.
PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients.
Gynecol Oncol
; 173: 98-105, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105063
9.
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Gynecol Oncol
; 170: 186-194, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706645
10.
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours.
Br J Clin Pharmacol
; 89(3): 1046-1055, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36131603
11.
Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number.
J Immunol
; 206(10): 2265-2270, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931486
12.
Immunotherapy for GTN: a new paradigm.
Gynecol Obstet Invest
; 2023 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37703867
13.
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era.
Br J Cancer
; 127(1): 79-83, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361918
14.
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
N Engl J Med
; 381(25): 2416-2428, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851799
15.
Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.
Ann Surg Oncol
; 29(3): 2104-2113, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713369
16.
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
Gynecol Oncol
; 165(1): 30-39, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123771
17.
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
Gynecol Oncol
; 166(3): 389-396, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902297
18.
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Gynecol Oncol
; 164(1): 18-26, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34696892
19.
Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
Am J Obstet Gynecol
; 225(4): 401.e1-401.e9, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019886
20.
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study.
Lancet Oncol
; 21(9): 1155-1164, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32771088